Identification of a novel intracellular function of the secreted ribonuclease RNASE1 in inhibiting gene expression
RNASE1 is a ribonuclease secreted by cells and degrades extracellular RNAs. Here, we unexpectedly found that endogenous RNASE1, in addition to being secreted, is predominantly localized to the nucleus and primarily functions to inhibit gene expression in human colorectal cancer (CRC) cells. In CRC cells, RNASE1 expression is highly cell type-specific and is restricted to well-differentiated cells where its transcription is activated by the pioneer transcription factor FOXA1. Using CRISPR interference (CRISPRi) utilizing three independent sgRNAs targeting the RNASE1 locus followed by RNA-seq, we found that upon depletion of RNASE1, most of the differentially expressed RNAs are modestly but significantly upregulated suggesting that RNASE1 may predominantly function to inhibit gene expression. In CRC patients, RNASE1 is significantly downregulated and high RNASE1 expression is associated with better patient survival indicating a potential tumor suppressive function. Consistent with this, RNASE1 depletion results in increased proliferation and clonogenicity indicating that RNASE1 inhibits the growth of CRC cells. Finally, a promising RNASE1 target amongst the most significantly upregulated mRNAs upon RNASE1 depletion is DKK1 (Dickkopf inhibitor 1) which is upregulated in CRC and negatively regulated by RNASE1. Collectively, these data uncover an intracellular function of RNASE1 in inhibiting gene expression and CRC cell proliferation. Overall design: mRNAseq profile of established RNASE1 CRISPRi cell lines